April 2nd Tariffs Proclamation Increases Pressure on US Pharma Imports
On April 2, 2026, President Trump imposed 100% tariffs under Section 232 on patented pharmaceuticals and APIs. Exemptions for generics, MFN agreements, and onshoring. Impact on US imports analysed.
April 2nd Tariffs Proclamation Increases Pressure on US Pharma Imports Read More »
